相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses
A. Sharma et al.
GENE THERAPY (2010)
High Probability of Avian Influenza Virus (H7N7) Transmission from Poultry to Humans Active in Disease Control on Infected Farms
Marian E. H. Bos et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Comparative Efficacy of Hemagglutinin, Nucleoprotein, and Matrix 2 Protein Gene-Based Vaccination against H5N1 Influenza in Mouse and Ferret
Srinivas S. Rao et al.
PLOS ONE (2010)
A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice
Julia Steitz et al.
PLOS ONE (2010)
Estimating Influenza-Associated Deaths in the United States
William W. Thompson et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2009)
Unraveling the Mystery of Swine Influenza Virus
Taia T. Wang et al.
CELL (2009)
Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
Clayton Harro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Protection of chickens against avian influenza with nonreplicating adenovirus-vectored vaccine
H. Toro et al.
POULTRY SCIENCE (2009)
Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model
Anurag Sharma et al.
VIROLOGY (2009)
Towards Purification of Adenoviral Vectors Based on Membrane Technology
Cristina Peixoto et al.
BIOTECHNOLOGY PROGRESS (2008)
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults
Frances H. Priddy et al.
CLINICAL INFECTIOUS DISEASES (2008)
Vaccines against epidemic and pandemic influenza
Mary Hoelscher et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Oral adenoviral-based vaccines: historical perspective and future opportunity
Sean N. Tucker et al.
EXPERT REVIEW OF VACCINES (2008)
Development of a Vaccine Against Pandemic Influenza Viruses: Current Status and Perspectives
Petr O. Ilyinskii et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2008)
The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development?
Rafick-Pierre Sekaly
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo
Daniel M. Appledorn et al.
JOURNAL OF IMMUNOLOGY (2008)
A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses
Mary A. Hoelscher et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus
Neetu Singh et al.
MOLECULAR THERAPY (2008)
Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
Maria A. Croyle et al.
PLOS ONE (2008)
Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold-adapted vaccine versus DNA prime-adenovirus boost strategies
Chia-Yun Lo et al.
VACCINE (2008)
Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses
David H. Holman et al.
VACCINE (2008)
Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine
Haroldo Toro et al.
VACCINE (2008)
New pre-pandemic influenza vaccines: An egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice
M. A. Hoelscher et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein
Soumitra Roy et al.
VACCINE (2007)
Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors
Tomoko Yamaguchi et al.
HUMAN GENE THERAPY (2007)
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine
Andrew T. Catanzaro et al.
VACCINE (2007)
Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator
Marcelo Nociari et al.
JOURNAL OF VIROLOGY (2007)
Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways
Jiangao Zhu et al.
JOURNAL OF VIROLOGY (2007)
Adenovirus-based prime-boost immunization for rapid vaccination against anthrax
Michael J. McConnell et al.
MOLECULAR THERAPY (2007)
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
Jinyong Luo et al.
NATURE PROTOCOLS (2007)
Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1
Stephen Mark Tompkins et al.
EMERGING INFECTIOUS DISEASES (2007)
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector
Andrew T. Catanzaro et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus
Ronald D. Wesley et al.
VETERINARY MICROBIOLOGY (2006)
Vaccines for seasonal and pandemic influenza
Kristin L. Nichol et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa
Anna R. Thorner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobactetium bovis BCG immunization against pulmonary tuberculosis
Michael Santosuosso et al.
INFECTION AND IMMUNITY (2006)
Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity
Anja Krause et al.
JOURNAL OF VIROLOGY (2006)
Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination
SD Perkins et al.
VACCINE (2006)
Current strategies and future directions for eluding adenoviral vector immunity
Dinesh S. Bangari et al.
CURRENT GENE THERAPY (2006)
Development of nonhuman adenoviruses as vaccine vectors
DS Bangari et al.
VACCINE (2006)
Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice
MA Hoelscher et al.
LANCET (2006)
Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization
WT Gao et al.
JOURNAL OF VIROLOGY (2006)
Viral vaccines for cancer immunotherapy
Andrew Eisenberger et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2006)
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
SL Epstein et al.
VACCINE (2005)
Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus
RD Wesley et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2005)
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys
A Nanda et al.
JOURNAL OF VIROLOGY (2005)
Characterization of the reconstructed 1918 Spanish influenza pandemic virus
TM Tumpey et al.
SCIENCE (2005)
Downstream processing of viral vectors and vaccines
R Morenweiser
GENE THERAPY (2005)
Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity
M Hashimoto et al.
INFECTION AND IMMUNITY (2005)
Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting
C Rollier et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-Ad5 immunity
AAC Lemckert et al.
JOURNAL OF VIROLOGY (2005)
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein
SM Sumida et al.
JOURNAL OF IMMUNOLOGY (2005)
Adenoviral vectors for mucosal vaccination against infectious diseases
M Santosuosso et al.
VIRAL IMMUNOLOGY (2005)
Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid
S Worgall et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The induction of inflammation by adenovirus vectors used for gene therapy
MJ Cotter et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Development and assessment of human adenovirus type 11 as a gene transfer vector
D Stone et al.
JOURNAL OF VIROLOGY (2005)
Good manufacturing practice production of adenoviral vectors for clinical trials
M Lusky
HUMAN GENE THERAPY (2005)
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
KR Van Kampen et al.
VACCINE (2005)
Phylogenetic analysis of fowl adenoviruses
G Meulemans et al.
AVIAN PATHOLOGY (2004)
Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A
BD Brown et al.
BLOOD (2004)
Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus
RD Wesley et al.
VACCINE (2004)
Adenovirus vectors activate survival pathways in lung epithelial cells
DM Flaherty et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
The innate immune response to adenovirus vectors
DA Muruve
HUMAN GENE THERAPY (2004)
Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: Low seroprevalence and non-cross-reactivity with Ad5
L Holterman et al.
JOURNAL OF VIROLOGY (2004)
Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo
DA Muruve et al.
JOURNAL OF VIROLOGY (2004)
Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors
JW Shiver et al.
ANNUAL REVIEW OF MEDICINE (2004)
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity
DH Barouch et al.
JOURNAL OF IMMUNOLOGY (2004)
Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture
DS Bangari et al.
VIRUS RESEARCH (2004)
Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system
F Lemiale et al.
JOURNAL OF VIROLOGY (2003)
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
NJ Sullivan et al.
NATURE (2003)
Development of adenovirus serotype 35 as a gene transfer vector
PS Reddy et al.
VIROLOGY (2003)
Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6™ cell culture under sparging conditions
LZ Xie et al.
BIOTECHNOLOGY AND BIOENGINEERING (2003)
Molecular basis of the inflammatory response to adenovirus vectors
Q Liu et al.
GENE THERAPY (2003)
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
K Jooss et al.
GENE THERAPY (2003)
Progress and problems with the use of viral vectors for gene therapy
CE Thomas et al.
NATURE REVIEWS GENETICS (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Human adenovirus type 35: nucleotide sequence and vector development
W Gao et al.
GENE THERAPY (2003)
CD46 is a cellular receptor for group B adenoviruses
A Gaggar et al.
NATURE MEDICINE (2003)
Construction, rescue, and characterization of vectors derived from ovine atadenovirus
P Loser et al.
JOURNAL OF VIROLOGY (2003)
Serum-free suspension cultivation of PER.C6® cells and recombinant adenovirus production under different pH conditions
LZ Xie et al.
BIOTECHNOLOGY AND BIOENGINEERING (2002)
Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response
G Sailaja et al.
GENE THERAPY (2002)
Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/I/68 (H3N2)
M Tang et al.
ARCHIVES OF VIROLOGY (2002)
A new scalable method for the purification of recombinant adenovirus vectors
AP Green et al.
HUMAN GENE THERAPY (2002)
Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system
P Ng et al.
JOURNAL OF VIROLOGY (2002)
Adenovirus vector-induced inflammation:: Capsid-dependent induction of the C-C chemokine RANTES requires NF-κB
GP Bowen et al.
HUMAN GENE THERAPY (2002)
Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10
LA Tibbles et al.
JOURNAL OF VIROLOGY (2002)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
JW Shiver et al.
NATURE (2002)
Replication-defective vector based on a chimpanzee adenovirus
SF Farina et al.
JOURNAL OF VIROLOGY (2001)
Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector
IH Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium
MA Perricone et al.
HUMAN GENE THERAPY (2001)
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications
PM Joseph et al.
HUMAN GENE THERAPY (2001)
Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors
MA Schnell et al.
MOLECULAR THERAPY (2001)
Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells
YS Tsao et al.
CYTOTECHNOLOGY (2001)
Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway
AE Morelli et al.
JOURNAL OF VIROLOGY (2000)
Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response
SK Mittal et al.
VACCINE (2000)
The complete nucleotide sequence of fowl adenovirus type 8
D Ojkic et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: Implications in gene therapy
S Moffatt et al.
VIROLOGY (2000)
Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-κB
SL Borgland et al.
JOURNAL OF VIROLOGY (2000)
Canine adenovirus vectors: an alternative for adenovirus mediated gene transfer
EJ Kremer et al.
JOURNAL OF VIROLOGY (2000)
DNA vaccines for influenza virus: Differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein
TM Pertmer et al.
JOURNAL OF VIROLOGY (2000)
分享论文
